Top of page
Health

Cycles of Reward: New Insight into ADHD Treatment

girl with ADHD playing

Attention-Deficit Hyperactivity Disorder (ADHD) is a widespread condition with complex underlying causes. A stimulant drug called methylphenidate is a common ADHD treatment that impacts the brain’s levels of dopamine, a neurotransmitter involved in systems of reward; however, methylphenidate has a potential for abuse, and its therapeutic effects are poorly understood.

To explore methylphenidate’s varied interactions with dopamine systems in the brain, researchers at the Okinawa Institute of Science and Technology Graduate University (OIST) in collaboration with scientists at the University of Otago and the University of Auckland in New Zealand, investigated the actions of the drug in rats. Using dopamine cell recordings, electrochemical monitoring and computer modeling, they discovered a type of feedback loop that modulates dopamine levels in the rats’ brains in response to the drug. This regulatory process may shed light on methylphenidate’s therapeutic properties in ADHD. The researchers’ findings are published in Progress in Neurobiology.

“We know quite a bit about how methylphenidate works at the molecular level, but not how it affects greater neural systems. It’s still a mystery how this drug improves symptoms of ADHD,” said Professor Jeff Wickens of OIST’s Neurobiology Research Unit. “This mystery leads us to explore how different parts of the brain interact to produce therapeutic effects.”

To carry out their research, the international team administered methylphenidate at a concentration of 5.0 mg/kg to a group of adult male rats, while a control group received no drugs. After surgically implanting electrodes in the rats’ brains, the researchers used an electrochemical technique called voltammetry to monitor real-time changes in cellular dopamine concentration in brain regions involved in ADHD. The researchers also took measurements in live brain slices of rats’ midbrains and forebrains.

To help understand the data, the scientists at OIST, including technician Kavinda Liyanagama, designed a computer program to model the effects of methylphenidate on dopamine systems.

You might also like

Portrait of premature newborn Portrait of premature newborn

One million annual deaths caused by premature births: UN

An estimated 13.4 million babies were born premature in 2020,…

Doctor consulting with patient Back problems Doctor consulting with patient Back problems

Solution offers relief for Australians struggling with chronic back pain

Long-term sufferers of chronic back pain experienced dramatic reductions in…

Young Downs Syndrome Man Baking Cupcakes In Kitchen At Home Young Downs Syndrome Man Baking Cupcakes In Kitchen At Home

Study reveals lifespan morbidities in people with Down Syndrome

New research from the Institute of Psychiatry, Psychology & Neuroscience…

man holding his painful knee man holding his painful knee

Study raises doubts on the effectiveness of multiple osteoarthritis treatments

Recruiting osteoarthritis patients with a lot of pain to clinical…